Search filters

An open label phase II study evaluating first-line EGFR tyrosine kinase inhibitor erlotinib in non-small cell lung cancer patients with tumors showing high EGFR gene copy number

Image Image of a generic work. The text above it indicates that there is no free image of the work available, and that if you own one, you can click on the placeholder link to upload it.
Description scientific article published on 04 December 2016
Author/s

author: Rafal Dziadziuszko  Ewa Szutowicz-Zielińska  Krzysztof Konopa  Wojciech Biernat  Tomasz Burzykowski  Renata Duchnowska  Magdalena Ratajska  Aleksandra Szczesna  Janusz Limon  Jacek Jassem  Anna Kowalczyk 

Publication date December 4, 2016
Language English
Country of origin
Wikipedia link
Copyright status
Missing/wrong data? Edit Wikidata item